Advertisement

Topics

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

08:14 EDT 27 Apr 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies is a new report from Firstword published on 2015-04-26. This 54+-page report is available from $3900.

As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with oncologists becomes ever more critical.Fine tuning their performance through smarter delivery and high quality interaction is an increasingly important aspect of establishing and maintaining front line, product level access and education.In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord provides robust insight on the performance and physician satisfaction across 12 Medical Affairs teams across 4 key indications; Breast Cancer, Melanoma, Non-Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma.Using its proprietary analytics, EdgeMap and Need-Gap analysis, FirstWord offers an important new advanced analysis of survey results that is both timely and critical to the current oncology drugs market.EdgeMapWhat is EdgeMap Analysis? This report includes slides that provide advance analysis of the survey results using EdgeMap analysis, a proprietary analytics tool. EdgeMap provides an integrated, comparative analysis of the competitive set of products being evaluated in the study. It offers an overview of the market and provides a clear portrait of each product’s position within its competitive environment. Key BenefitsIn this report, gain insight from key pharma stakeholders with a vested interest in physician perspectives on oncology brand performance.Gain insight into how oncologists and haematologist-oncologists rate Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC, and Renal Cell CarcinomaUnderstand the key issues for which physicians require Medical Affairs team supportLearn which attributes physicians most value in relation to Medical Affairs team servicesIdentify which marketed and pipeline products were rated most highly across numerous measuresDetermine which media and frequency of interaction is perceived the most positivelyBenefit from FirstWord’s proprietary analytics tool, EdgeMap and Need-Gap. EdgeMap offers an integrated, comparative analysis of the evaluated products. Need-Gap provides guidance on opportunities for brand positioning and communication.Key Fact: Interviewing MethodologyData was collected via a 15-minute Internet-based questionnaire.Top Report FeaturesFilled with charts and up-to-the-minute survey analysis, this report offers:Precise and timely EdgeMap and Need-Gap analytics into the perceptions around Medical Affairs team performances and areas of improvementOverview of key rankings for eight marketed and four pipeline productsExamination of physicians’ current usage of Medical Affairs teams servicesKey findings regarding the most and least important attributes of Medical Affairs teams to physiciansSample DistributionKey Fact: Sample DistributionA total of 100 medical oncologists and hematologist-oncologists across US participated in this study.70 Medical Oncologists, 30 Hematologist-oncologistsGet Answers to these QuestionsHow do oncologists perceive the role of Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC, and Renal Cell Carcinoma?How do physicians use Medical Affairs teams’ services?What is the optimal frequency of interactions between Medical Affairs teams and physicians?What is each product’s position within its competitive environment?Which attributes of Medical Affairs teams are most likely to drive competitive advantage?Which drugs offered the best service and claimed the highest ratings for Medical Affairs support?What are the opportunities for corporate and brand positioning and communication?NeedGapWhat is Need-Gap Analysis?This report includes slides that provide advance analysis of the survey results…

1.Current Status of Interactions with Different Medical Affairs Teams
1.1.Interactions in the past 6 months with medical affairs teams for each product
1.2.Details of interactions on different aspects
1.3.Current frequency of interactions with medical affair teams for each product

2.Competitive Evaluation of Medical Affairs Teams Performance on Various Attributes
2.1.Evaluation of overall quality of interactions with medical affairs teams for each product
2.2.Attribute importance of medical affairs teams roles to physicians’ practice
2.3.EdgeMap analysis by therapy area - competitive evaluation on medical affairs teams performance on attributes
2.4.Competitive evaluation of physicians satisfaction of interaction with medical affairs
2.5.Need-Gap analysis by product

3.Preferred Interaction Media, Frequency, and Suggestions for Improvement
3.1.Preferred interaction media and frequency
3.2.Suggestions for improvement

4.Appendix
4.1.Physician profile
4.2.Detailed satisfaction scores

For more information open Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies.

Original Article: Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies

NEXT ARTICLE

More From BioPortfolio on "Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies"

Advertisement
Quick Search
Advertisement
Advertisement